Henoch-Schönlein purpura (HSP) is a systemic vasculitis affecting small vessels. It is the most common systemic vasculitis in children and is rare in adults.
| INTRODUCTION
Henoch-Schönlein purpura (HSP), also termed immunoglobulin A (IgA) vasculitis, is a self-limiting, systemic, autoimmune complex, leukocytoclastic vasculitis, primarily seen in children, with skin, joints, gastrointestinal tract, and renal involvement. Its etiology is unclear, but it is associated with infections (bacterial, viral, parasitic), medications, vaccinations, tumors (non-small cell lung cancer, prostate cancer, and hematological malignancies), alpha-1-antitrypsin deficiency, and Familial Mediterranean Fever. 1 HSP has been reported in patients as young as 6 months and as old as 86 years; however, 90% of patients are younger than 10 years. 2 The estimated annual incidence of HSP is 3-26.7/100 000 for children and 0.8-1.8/100 000 for adults. 3 The condition is commonly self-limiting, and management usually entails symptomatic treatment and the use of immunosuppressive therapy. Furthermore, there is limited discussion relating to intestinal manifestations of adult-onset HSP. Based on this, we describe a case of small bowel ischemia in a 63-year-old male with previously undiagnosed HSP.
| CASE REPORT
A 63-year-old male with a history of hypertension presented with multiple erythematous papules with crusted wounds on both lower legs for 6 days and visited the dermatology outpatient department. An infection and immunology screen was performed, and the patient was given a weeklong course of oral prednisolone at a dose of 5 mg twice daily. Laboratory tests showed no leukocytosis (white blood cells count: 5600/μL); Hb: 14.0 g/dL; Platelet count: 187000/μL; Cryoglobulin: Negative; antinuclear antibody: Negative; Anti-cardiolipin IgG: Negative; Anticardiolipin IgM: Negative. A week later, the patient visited the emergency department and required admission due to the sudden onset of generalized abdominal pain and fullness. An initial kidney, ureter, and bladder radiography showed localized ileus of the gastrointestinal tract and suspected small bowel obstruction is noted. In addition, laboratory tests showed elevated levels of C-reactive protein, urea nitrogen, and creatinine. Stool for occult blood was positive. Urinalysis indicated proteinuria and microscopic hematuria. Upper gastrointestinal endoscopy revealed a mucosal break less than 5 mm over the esophagogastric junction, hyperemic and edematous mucosa in the antrum, and hyperemic mucosa in both the bulb and second portion of duodenum. However, computed tomography of the abdomen revealed mural swelling of the long segmental small intestinal loop, extensive small bowel wall thickening, and the presence of ascites without evidence of mechanical obstruction or perforation ( Figure 1 ). The next day, the severe diffuse abdominal pain was progressive, and the patient deteriorated rapidly developing peritonitis. A surgical consultation with an emergency laparotomy revealed massive bloody ascites of about 2150 mL and ischemic change of the small bowel from the jejunum to the distal ileum ( Figure 2 ). Ischemic small bowel resection with an anastomosis was performed. The pathology report for the ischemic small bowel segment revealed acute necrotizing vasculitis with a fibrinoid necrotic wall and neutrophil infiltrate present at the small intestinal wall (Figure 3 ). The size of involved vessels ranged from small caliber up to 1 mm in diameter. In addition, many reddish papules were located on his lower limbs but did not itch or cause pain. The histopathology report for the skin biopsy showed leukocytoclastic vasculitis and positive immunofluorescence for IgA in the wall of dermal papillary vessels ( Figure 4 ). The diagnosis of HSP was made based on both clinical features and biopsy findings. Over the next 10 days, the patient made steady progress toward recovery, and he was discharged from hospital in stable condition.
| DISCUSSION
HSP is an acute systemic small vessel IgA-dominant vasculitis characterized by classic palpable purpura, arthritis, abdominal pain, and renal disease. 2, 4 It is the most common vasculitis of childhood and commonly occurs in children younger than 10 years old; however, it is known to affect young adults also. The clinical presentation of HSP is more severe among adults and tends to be atypical with higher rates of both severe and atypical gastrointestinal problems and delayed renal complications. Gastrointestinal involvement is one of the most common manifestations of HSP in adults. It is often the most debilitating manifestation of HSP and is characterized by colicky abdominal pain, vomiting, and gastrointestinal hemorrhage. These symptoms are caused by hemorrhage and edema within the bowel and wall mesentery. Serious complications related to gastrointestinal involvement include intestinal perforation, ischemic bowel, intussusceptions, fistula, massive bleeding, protein-losing enteropathy, hemorrhagic ascites, and pancreatitis. [5] [6] [7] The small intestine is the most common site involved with a predilection for the terminal ileum (60%) and the second portion of the duodenum (53%). The rectum (80%) is the most frequently affected segment of the lower gastrointestinal tract. 8 HSP is a clinical diagnosis based on both clinical signs and symptoms, but when the presentation is atypical, tissue biopsy may be helpful. 4 On images produced by computed tomography scanning, bowel involvement is seen as a multifocal, symmetrical, and circumferential wall thickening with a target appearance. The target pattern is appreciable after administration of intravenous contrast and consists of enhancing mucosal and serosal layers due to hyperemia with intervening hypodense submucosal layer due to edema. 5 The target sign is not specific for vasculitis and can be seen in many other conditions including ischemic bowel disease, idiopathic inflammatory bowel disease, infectious enterocolitis, radiation enteritis, and others. Imaging findings in the early phase of mesenteric ischemia, which are characterized by mucosal hyperemia and edema, are indistinguishable from those in HSP.
In most cases, HSP disappears spontaneously without treatment. Symptomatic treatment will be sufficient for symptoms such as rash and arthritis. Acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) can be used to treat arthritis, but NSAIDs should be avoided in patients with both gastrointestinal and renal manifestations. Aspirin should be avoided in children. The treatment of HSP with corticosteroids is controversial. Several case series have reported better outcomes in adult patients with gastrointestinal and renal involvement who were treated with corticosteroids. 4, 9 Steroid treatment improves gastrointestinal symptoms at an early stage but does not prevent the recurrence of abdominal pain attacks. Steroids decrease intestinal wall edema, and thus symptoms improve or disappear. In a randomized, double-blind, placebo-controlled trial, prednisone was effective in reducing abdominal pain; the incidence of severe abdominal pain requiring hospitalization was greater in the placebo group than in the prednisone group. 10 Prednisone can be started at 1 to 2 mg/kg/day for one to two weeks, tapering down to 0.5 mg/kg/day over the next week, and then 0.5 mg/kg every other day for one more week. 11 Intravenous steroids can be administered if the patient does not tolerate oral steroids. Early steroid therapy decreases gastrointestinal symptoms within 2 days compared with 12.3 days in patients without steroids and may decrease HSP or gastrointestinal recurrence and reduce renal progression. Steroids may prevent major complications such as gastrointestinal bleeding or intussusception.
HSP is uncommon after the adolescent age group. The diagnosis of HSP is extremely challenging when it precedes other manifestations, especially the cutaneous rash. Non-thrombocytopenic palpable purpura with multiple organ involvement (gastrointestinal, kidney, and joints) should prompt the differential diagnosis of adults who present with acute abdominal symptoms accompanied by the above symptoms and signs that may indicate an underlying vasculitic process. Prompt diagnosis and management of HSP can prevent potentially lifethreatening complications.
